Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma

Autor: Jones, D.A., Candio, P., Shakir, R., Ramroth, J., Wolstenholme, J., Gray, A.M., Cutter, D.J., Ntentas, G.
Zdroj: In Clinical Oncology May 2023 35(5):301-310
Databáze: ScienceDirect